Putnam Investments LLC Kiniksa Pharmaceuticals, Ltd. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Putnam Investments LLC holds 39,486 shares of KNSA stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,486
Previous 40,742
3.08%
Holding current value
$1.29 Million
Previous $707,000
2.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $1.13B
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...